WallStSmart

Agnico Eagle Mines Limited (AEM)vsAmgen Inc (AMGN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amgen Inc generates 175% more annual revenue ($37.22B vs $13.54B). AEM leads profitability with a 39.5% profit margin vs 21.0%. AMGN appears more attractively valued with a PEG of 2.18. AEM earns a higher WallStSmart Score of 75/100 (B+).

AEM

Strong Buy

75

out of 100

Grade: B+

Growth: 10.0Profit: 9.5Value: 4.7Quality: 8.5
Piotroski: 6/9Altman Z: 2.83

AMGN

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 9.0Value: 4.7Quality: 5.0
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AEMOvervalued (-12.6%)

Margin of Safety

-12.6%

Fair Value

$192.97

Current Price

$193.21

$0.24 premium

UndervaluedFair: $192.97Overvalued
AMGNFair Value (-2.2%)

Margin of Safety

-2.2%

Fair Value

$321.89

Current Price

$331.70

$9.81 premium

UndervaluedFair: $321.89Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AEM6 strengths · Avg: 9.8/10
Profit MarginProfitability
39.5%10/10

Keeps 40 of every $100 in revenue as profit

Operating MarginProfitability
62.8%10/10

Strong operational efficiency at 62.8%

Revenue GrowthGrowth
66.1%10/10

Revenue surging 66.1% year-over-year

EPS GrowthGrowth
108.6%10/10

Earnings expanding 108.6% YoY

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Market CapQuality
$93.89B9/10

Large-cap with strong market position

AMGN5 strengths · Avg: 9.2/10
Return on EquityProfitability
101.3%10/10

Every $100 of equity generates 101 in profit

Operating MarginProfitability
33.8%10/10

Strong operational efficiency at 33.8%

Market CapQuality
$177.71B9/10

Large-cap with strong market position

Profit MarginProfitability
21.0%9/10

Keeps 21 of every $100 in revenue as profit

Free Cash FlowQuality
$1.48B8/10

Generating 1.5B in free cash flow

Areas to Watch

AEM1 concerns · Avg: 2.0/10
PEG RatioValuation
28.152/10

Expensive relative to growth rate

AMGN3 concerns · Avg: 4.0/10
PEG RatioValuation
2.184/10

Expensive relative to growth rate

Price/BookValuation
19.5x4/10

Trading at 19.5x book value

EPS GrowthGrowth
4.4%4/10

4.4% earnings growth

Comparative Analysis Report

WallStSmart Research

Bull Case : AEM

The strongest argument for AEM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 39.5% and operating margin at 62.8%. Revenue growth of 66.1% demonstrates continued momentum.

Bull Case : AMGN

The strongest argument for AMGN centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 21.0% and operating margin at 33.8%.

Bear Case : AEM

The primary concerns for AEM are PEG Ratio.

Bear Case : AMGN

The primary concerns for AMGN are PEG Ratio, Price/Book, EPS Growth.

Key Dynamics to Monitor

AEM profiles as a growth stock while AMGN is a mature play — different risk/reward profiles.

AEM carries more volatility with a beta of 0.57 — expect wider price swings.

AEM is growing revenue faster at 66.1% — sustainability is the question.

AMGN generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

AEM scores higher overall (75/100 vs 62/100), backed by strong 39.5% margins and 66.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Agnico Eagle Mines Limited

BASIC MATERIALS · GOLD · USA

Agnico Eagle Mines Limited is engaged in the exploration, development and production of mineral properties in Canada, Sweden and Finland. The company is headquartered in Toronto, Canada.

Visit Website →

Amgen Inc

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

Visit Website →

Want to dig deeper into these stocks?